CHYM · XBRL financial data
Chime Financial financial statements, every quarter
The same tables from 5 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (CHYM's year ends in late December)
| In millions of dollars | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|
| Revenue | 528 | 544 | 596* | 647 | 670 |
| Cost of goods and services sold | 67 | 69 | 66* | 67 | 75 |
| Gross profit | 461 | 474 | 530* | 580 | 595 |
| Research and development | 622 | 124 | 111* | 110 | 112 |
| General and administrative | 280 | 77 | 109* | 70 | 80 |
| Total operating expenses | 1,392 | 539 | 584* | 534 | 574 |
| Operating income (loss) | (931) | (65) | (54)* | 46 | 21 |
| Other income (expense) | 6 | 10 | 9* | 8 | 7 |
| Income tax expense (benefit) | (1) | 0 | 0* | 0 | 0 |
| Net income (loss) | (923) | (55) | (45)* | 53 | 28 |
| Earnings per share, basic USD per share | (7.29) | (0.15) | — | 0.14 | 0.07 |
| Earnings per share, diluted USD per share | (7.29) | (0.15) | — | 0.13 | 0.07 |
| Weighted average shares, basic millions of shares | 127 | 372 | — | 382 | 380 |
| Weighted average shares, diluted millions of shares | 127 | 372 | — | 400 | 393 |
Balance sheet
CSVFiscal quarters (CHYM's year ends in late December)
| In millions of dollars | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 868 | 445 | 466 | 608 | 536 |
| Marketable securities | 225 | 634 | 588 | 404 | 527 |
| Accounts receivable | 230 | 238 | 258 | 294 | 288 |
| Prepaid and other current assets | 73 | 91 | 107 | 87 | 71 |
| Total current assets | 1,736 | 1,759 | 1,756 | 1,744 | 1,790 |
| Property and equipment, net | 89 | 86 | 94 | — | 97 |
| Right-of-use asset | 46 | 86 | 83 | 81 | 79 |
| Goodwill | 27 | 27 | 27 | 27 | 27 |
| Total assets | 1,902 | 1,962 | 1,965 | 1,950 | 1,997 |
| Accounts payable | 52 | 40 | 39 | 38 | 36 |
| Accrued liabilities | 82 | 78 | 81 | 94 | 104 |
| Total current liabilities | 360 | 356 | 388 | 344 | 387 |
| Lease liability, non-current | 75 | 126 | 123 | 121 | 118 |
| Total liabilities | 474 | 519 | 563 | 509 | 592 |
| Accumulated deficit | (3,275) | (3,329) | (3,374) | (3,321) | (3,293) |
| Total stockholders' equity | 1,428 | 1,443 | 1,402 | 1,441 | 1,405 |
| Total liabilities and equity | 1,902 | 1,962 | 1,965 | 1,950 | 1,997 |
| Common shares outstanding (cover page) millions of shares | 0 | 0 | 0 | — | — |
Cash flows
CSVFiscal quarters (CHYM's year ends in late December)
| In millions of dollars | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|
| Net income (loss) | (923) | (55) | (45)* | 53 | 28 |
| Stock-based compensation | 910* | 85* | 67* | 61 | 69* |
| Depreciation and amortization | 7* | 8* | 8* | 8 | 8* |
| Net cash from operating activities | 28* | 17* | 33* | 87 | 207* |
| Purchases of property and equipment | — | 2* | — | — | — |
| Net cash from investing activities | 72* | (424)* | 55* | 127 | (142)* |
| Share repurchases | 0* | 0* | 78* | 86 | 136* |
| Net cash from financing activities | 450* | (17)* | (65)* | (73) | (87)* |
| Net change in cash | 551* | (423)* | 22* | 141 | (21)* |
Compare with peers
SIC 6199 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 6199 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
- A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Chime Financial | 536 | 670 | 207* | not reported | — | 10-QJun 30, 2026 |
| IREN | 5,896 | 137* | year only | not reported | — | 10-KJun 30, 2026 |
| MARA Holdings | 421 | 175 | (224)* | 386.3M | 1.9 quarters | 10-QJun 30, 2026 |
| Upstart Holdings | 461 | 371 | (20)* | 98.9M | 4.7 quarters | 10-QSep 30, 2026 |
| Core Scientific, Inc./tx | 1,770 | 164 | (19)* | 321.3M | 93.5 quarters | 10-QJun 30, 2026 |
| SoFi Technologies | 3,126 | 154 | (3,890)* | 1.3B | — | 10-QJun 30, 2026 |
| Dave | 210 | 171 | 68* | not reported | — | 10-QJun 30, 2026 |
| Burford Capital | 697 | 111 | 52* | 219.6M | — | 10-QJun 30, 2026 |
| Synchrony Financial | 15,901 | not reported | 2,498* | 311.4M | — | 10-QSep 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.